Advanced Gastrointestinal Stromal Tumor Gist clinical trials

Explore recruiting advanced gastrointestinal stromal tumor gist clinical trials.

Recruiting advanced gastrointestinal stromal tumor gist studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Gastrointestinal Stromal Tumor Gist trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Portugal, Netherlands, Denmark, Spain, Italy, Germany +2 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

An International, Phase 3, Randomized, Multicenter, Open-label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated with Imatinib (INSIGHT)

Norway, France, Germany, Netherlands, Spain, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ATEZOGIST – A prospective, randomized, multicenter, comparative study of the efficacy of imatinib resumption combined with atezolizumab versus imatinib resumption alone in patients with unresectable advanced gastrointestinal stromal tumors (GIST) after failure of standard treatments

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Gastrointestinal Stromal Tumor Gist trials by city

Advanced Gastrointestinal Stromal Tumor Gist in Toronto Advanced Gastrointestinal Stromal Tumor Gist in Vancouver Advanced Gastrointestinal Stromal Tumor Gist in Montreal Advanced Gastrointestinal Stromal Tumor Gist in Calgary Advanced Gastrointestinal Stromal Tumor Gist in Edmonton Advanced Gastrointestinal Stromal Tumor Gist in Ottawa Advanced Gastrointestinal Stromal Tumor Gist in Winnipeg Advanced Gastrointestinal Stromal Tumor Gist in Quebec City Advanced Gastrointestinal Stromal Tumor Gist in Hamilton Advanced Gastrointestinal Stromal Tumor Gist in Kitchener Advanced Gastrointestinal Stromal Tumor Gist in London Advanced Gastrointestinal Stromal Tumor Gist in Halifax Advanced Gastrointestinal Stromal Tumor Gist in New York Advanced Gastrointestinal Stromal Tumor Gist in Los Angeles Advanced Gastrointestinal Stromal Tumor Gist in Chicago Advanced Gastrointestinal Stromal Tumor Gist in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease